Lariam's legacy.
The most-prescribed malaria drug could produce psychiatric side effects in more than one-quarter of all travelers who take it.
D000962:Antimalarials / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D003257:Consumer Product Safety; D004318:Doxycycline / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D015767:Mefloquine / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D001523:Mental Disorders / Q000139:chemically induced*; D009285:Naphthoquinones / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D002727:Proguanil / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000962:Antimalarials; D009285:Naphthoquinones; D004318:Doxycycline; D002727:Proguanil; D015767:Mefloquine